{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T05:21:46Z","timestamp":1735708906348,"version":"3.32.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>Childhood cancer treatment disrupts vaccination schedules and weakens or eliminates vaccine-induced immunity. In addition, post-treatment vaccine responses vary. This study aimed to assess post-treatment serum antibody levels and vaccine responses in children.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Pediatric patients treated at Hacettepe University between years 2015 and 2020, achieved remission after chemotherapy for lymphoma and solid tumors were included. Post-treatment vaccination status, serum antibody levels for hepatitis A (HAV), hepatitis B (HBV), varicella-zoster (VZV), measles-mumps-rubella (MMR), and changes in vaccine responses were retrospectively analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The study included 533 patients. Post-treatment seronegativity rates were: measles (83.5%), HAV (64%), rubella (60.1%), HBV (48.5%), VZV (43.3%), and mumps (28%). Post-treatment antibody loss was observed for measles (47.1%), HAV (31.9%), HBV (31.4%), mumps (28.6%), VZV (21.7%), and rubella (11.4%). Seropositivity after 1 vaccine dose was seen with HAV (83.6%), rubella (82.9%), HBV (81.4%), VZV (63.5%), mumps (45.4%), and measles (33.3%). Seropositivity after 2 vaccine doses was achieved with HAV (98.8%), VZV (84.6%), rubella (80%), HBV (80%), measles (32.2%), and mumps (36.2%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Post-treatment serological vaccine responses in children were lower than anticipated despite multiple doses. Given the potential need for periodic serological assessments and booster vaccinations, long-term follow-ups are planned.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000002961","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T15:15:26Z","timestamp":1731424526000},"page":"e19-e25","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Antibody Levels and Vaccine-induced Serologic Responses After Completion of Cancer Treatment in Pediatric Patients: A 6-Year Experience in Turkey on HAV, HBV, VZV, and MMR Vaccinations"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8425-3624","authenticated-orcid":false,"given":"Sebiha S.","family":"Gundesli","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Hacettepe University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6093-2027","authenticated-orcid":false,"given":"Melda","family":"Celik","sequence":"additional","affiliation":[{"name":"Division of Social Pediatrics, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Vaccine Institute, Hacettepe University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9061-4281","authenticated-orcid":false,"given":"Siddika Songul","family":"Yalcin","sequence":"additional","affiliation":[{"name":"Division of Social Pediatrics, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Vaccine Institute, Hacettepe University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guzide B.","family":"Aydin","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Faculty of Medicine and Cancer Institute, Hacettepe University, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8836-261X","authenticated-orcid":false,"given":"Nilgun","family":"Kurucu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Faculty of Medicine and Cancer Institute, Hacettepe University, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilgehan","family":"Yalcin","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Faculty of Medicine and Cancer Institute, Hacettepe University, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4911-1476","authenticated-orcid":false,"given":"Ali","family":"Varan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Faculty of Medicine and Cancer Institute, Hacettepe University, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1918-4407","authenticated-orcid":false,"given":"Tezer M.","family":"Kutluk","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Faculty of Medicine and Cancer Institute, Hacettepe University, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"R6-20241231","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/pbc.21864","article-title":"Immunization after the elective end of antineoplastic chemotherapy in children","volume":"52","author":"Fioredda","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20241231","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1016\/j.vaccine.2010.02.096","article-title":"Vaccinations in children with cancer","volume":"28","author":"Esposito","year":"2010","journal-title":"Vaccine"},{"key":"R8-20241231","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/cncr.20910","article-title":"International Classification of Childhood Cancer, third edition","volume":"103","author":"Steliarova-Foucher","year":"2005","journal-title":"Cancer"},{"key":"R9-20241231","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-020-09184-5","article-title":"Unvaccinated children as community parasites in National Qualitative Study from Turkey","volume":"20","author":"Yalcin","year":"2020","journal-title":"BMC Public Health"},{"key":"R10-20241231","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.arcped.2022.06.005","article-title":"Rates of childhood vaccine refusal in Turkey during 2016-2017: regional causes and solutions","volume":"29","author":"Yalcin","year":"2022","journal-title":"Arch Pediatr"},{"key":"R11-20241231","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1016\/j.vaccine.2014.04.042","article-title":"Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer","volume":"32","author":"Bochennek","year":"2014","journal-title":"Vaccine"},{"key":"R12-20241231","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1080\/21645515.2020.1802975","article-title":"Immunization status and re-immunization of childhood acute lymphoblastic leukemia survivors","volume":"17","author":"Toret","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"R13-20241231","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.pedneo.2016.04.003","article-title":"Immunization status in childhood cancer survivors: a hidden risk which could be prevented","volume":"58","author":"Fayea","year":"2017","journal-title":"Pediatr Neonatol"},{"key":"R14-20241231","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pbc.22256","article-title":"Survivors of childhood cancer: an Australian audit of vaccination status after treatment","volume":"54","author":"Crawford","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R15-20241231","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/10245332.2018.1460035","article-title":"Humoral immune response of childhood acute lymphoblastic leukemia survivors against the measles, mumps, and rubella vaccination","volume":"23","author":"Fouda","year":"2018","journal-title":"Hematology"},{"key":"R16-20241231","first-page":"370","article-title":"Hepatitis A virus age-specific seroprevalence after the implementation of a Toddlers\u2019 Vaccination in Turkey: shifting susceptibility to adolescents","volume":"55","author":"Akman","year":"2020","journal-title":"Turk Pediatr Arsivi"},{"key":"R17-20241231","doi-asserted-by":"crossref","first-page":"205","DOI":"10.5152\/TurkArchPediatr.2022.21194","article-title":"Hepatitis A vaccine effectiveness and seropositivity among 1- to 18-year-old children: 10-year results","volume":"57","author":"Samanci","year":"2022","journal-title":"Turk Arch Pediatr"},{"key":"R18-20241231","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5152\/eurasianjmed.2015.85","article-title":"A study on the age-related changes in hepatitis B and C virus serology","volume":"48","author":"Guclu","year":"2016","journal-title":"Eurasian J Med"},{"key":"R19-20241231","doi-asserted-by":"crossref","first-page":"493","DOI":"10.37990\/medr.1159364","article-title":"Ten year hepatitis A, B, And C seroprevalence trend in children: results from a single center","volume":"4","author":"Yildiz","year":"2022","journal-title":"Med Records"},{"key":"R20-20241231","first-page":"185","article-title":"Seroprevalence of mumps, varicella and rubella antibodies in children 1-16 years of age in eastern Turkey","volume":"48","author":"Gurgoze","year":"2006","journal-title":"Turk J Pediatr"},{"key":"R21-20241231","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2807\/ese.14.50.19444-en","article-title":"Rubella seroprevalence in children in Dogankent, a Rural Area of Adana Province in Turkey, January-February 2005","volume":"14","author":"Aytac","year":"2009","journal-title":"Euro Surveill"},{"key":"R22-20241231","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3906\/sag-1809-54","article-title":"Evaluation of measles immunity in Turkey: is it still a threat?","volume":"49","author":"Karaayvaz","year":"2019","journal-title":"Turk J Med Sci"},{"key":"R23-20241231","first-page":"1971","article-title":"Measles seroepidemiology in 3 cities in Turkey","volume":"26","author":"Gozalan","year":"2005","journal-title":"Saudi Med J Dec"},{"key":"R24-20241231","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.healthpol.2004.03.008","article-title":"Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey","volume":"72","author":"Alp","year":"2005","journal-title":"Health Policy (New York)"},{"key":"R25-20241231","doi-asserted-by":"crossref","first-page":"295","DOI":"10.26719\/2018.24.3.295","article-title":"Seroprevalence and social determinants of varicella in Turkey","volume":"24","author":"Hekimoglu","year":"2018","journal-title":"E Mediterr Health J"},{"key":"R26-20241231","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3947\/ic.2019.51.2.183","article-title":"Seroprevalence of hepatitis A virus in pediatric patients with hematologic malignancies after chemotherapy and hematopoietic cell transplantation","volume":"51","author":"Moon","year":"2019","journal-title":"Infect Chemother"},{"key":"R27-20241231","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5152\/eurasianjmed.2020.20047","article-title":"Revaccination in pediatric oncology patients: one center experience","volume":"53","author":"Yilmazbas","year":"2021","journal-title":"Eurasian J Med"},{"key":"R29-20241231","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3390\/vaccines8040780","article-title":"Universal single-dose vaccination against hepatitis A in children in a region of high endemicity","volume":"8","author":"Mikhailov","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"R30-20241231","doi-asserted-by":"crossref","first-page":"e2020014","DOI":"10.4084\/mjhid.2020.014","article-title":"The impact of chemotherapy after pediatric malignancy on humoral immunity to vaccine-preventable diseases","volume":"12","author":"Garonzi","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R31-20241231","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1097\/MPH.0000000000001072","article-title":"Assessment of humoral immunity to hepatitis B, measles, rubella, and mumps in children after chemotherapy","volume":"40","author":"Keskin Yildirim","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"R32-20241231","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00431-017-2970-4","article-title":"Assessment of hepatitis B virus antibody titers in childhood cancer survivors","volume":"176","author":"Fayea","year":"2017","journal-title":"Eur J Pediatr"},{"key":"R33-20241231","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/cncr.20384","article-title":"Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy","volume":"101","author":"Zignol","year":"2004","journal-title":"Cancer"},{"key":"R34-20241231","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4103\/0256-4947.87091","article-title":"Assessment of hepatitis B immunization status after antineoplastic therapy in children with cancer","volume":"31","author":"Karaman","year":"2011","journal-title":"Ann Saudi Med"},{"key":"R35-20241231","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/pbc.21277","article-title":"Loss of antibody titers and effectiveness of revaccination in post-chemotherapy pediatric sarcoma patients","volume":"49","author":"Yu","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R36-20241231","doi-asserted-by":"crossref","first-page":"e2019052","DOI":"10.4084\/mjhid.2019.052","article-title":"Serological changes against hepatitis B surface antigen in children and adolescents receiving chemotherapy for acute leukemia","volume":"11","author":"Shin","year":"2019","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R37-20241231","doi-asserted-by":"crossref","first-page":"2333794x211033452","DOI":"10.1177\/2333794X211033452","article-title":"HBV seroprotection and anamnestic response to booster vaccination in pediatric cancer survivors","volume":"8","author":"Suwanpakdee","year":"2021","journal-title":"Glob Pediatr Health"},{"key":"R38-20241231","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/08880019609030854","article-title":"Immune response of immunocompromised children with malignancies to a recombinant hepatitis B vaccine","volume":"13","author":"Polychronopoulou-Androulakaki","year":"1996","journal-title":"Pediatr Hematol Oncol"},{"key":"R39-20241231","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/0009922820915884","article-title":"Post-chemotherapy titer status and need for revaccination after treatment for childhood cancer","volume":"59","author":"Zhang","year":"2020","journal-title":"Clin Pediatr (Phila)"},{"key":"R40-20241231","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2016.02.040","article-title":"Strong additional effect of a second varicella vaccine dose in children in Germany, 2009-2014","volume":"173","author":"Siedler","year":"2016","journal-title":"J Pediatr"},{"key":"R41-20241231","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/08880018.2011.593093","article-title":"Seroconversion status after single dose and double doses of varicella vaccination in children with leukemia","volume":"29","author":"Cakir","year":"2012","journal-title":"Pediatr Hematol Oncol"},{"key":"R42-20241231","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJM198904063201403","article-title":"Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine","volume":"320","author":"Gershon","year":"1989","journal-title":"N Engl J Med"},{"key":"R43-20241231","first-page":"93","article-title":"Immunization of children with malignant diseases with the Oka-strain varicella vaccine","volume":"suppl 4","author":"Austgulen","year":"1985","journal-title":"Postgrad Med J"},{"key":"R44-20241231","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1600-0609.2004.00216.x","article-title":"Immunogenicity of a two-dose regime of varicella vaccine in children with cancers","volume":"72","author":"Leung","year":"2004","journal-title":"Eur J Haematol"},{"key":"R45-20241231","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/08880011003767720","article-title":"Measles, mumps, and rubella antibody status and response to immunization in children after therapy for acute lymphoblastic leukemia","volume":"27","author":"Aytac","year":"2010","journal-title":"Pediatr Hematol Oncol"},{"key":"R46-20241231","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/15513815.2021.1953653","article-title":"Assessment of humoral immunity to measles virus in cancer survivor children after chemotherapy: a case-control study","volume":"41","author":"Abdelaziz","year":"2022","journal-title":"Fetal Pediatr Pathol"},{"key":"R47-20241231","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.mph.0000163214.37147.5a","article-title":"Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia","volume":"27","author":"Ercan","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"issue":"suppl","key":"R49-20241231","doi-asserted-by":"crossref","first-page":"e22020","DOI":"10.1200\/JCO.2022.40.16_suppl.e22020","article-title":"Pediatric Cancer Registry in Turkey 2009-2021 (TPOG & TPHD)","volume":"40","author":"Kutluk","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T15:20:05Z","timestamp":1735658405000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002961","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"type":"print","value":"1077-4114"},{"type":"electronic","value":"1536-3678"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"2024-06-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}